ANTIRETROVIRAL THERAPY AND INTERRUPTION OF HIV PERINATAL TRANSMISSION

This publication has 39 references indexed in Scilit:

• A Transplacental Carcinogenicity Bioassay in CD-1 Mice with Zidovudine
  Fundamental and Applied Toxicology, 1997
• Zidovudine administered to women infected with human immunodeficiency virus type 1 and to their neonates reduces pediatric infection independent of an effect on levels of maternal virus
  The Journal of Pediatrics, 1997
• Maternal HIV-1 viral load and vertical transmission of infection: The Ariel Project for the prevention of HIV transmission from mother to infant
  Nature Medicine, 1997
• Influence of Other Maternal Variables on the Relationship between Maternal Virus Load and Mother-to-Infant Transmission of Human Immunodeficiency Virus Type 1
  The Journal of Infectious Diseases, 1997
• Estimating the Timing of Mother-to-Child Transmission of Human Immunodeficiency Virus in a Breast-Feeding Population in Kinshasa, Zaire
  The Journal of Infectious Diseases, 1996
• Nonclinical Toxicology Studies with Zidovudine: Genetic Toxicity Tests and Carcinogenicity Bioassays in Mice and Rats
  Fundamental and Applied Toxicology, 1996
• Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission
  The Lancet, 1996
• Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment
  New England Journal of Medicine, 1994
• Factors Predictive of Maternal-Fetal Transmission of HIV-1
  JAMA, 1994
• Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus
  The Journal of Pediatrics, 1993